Absorption of Casein Antihypertensive Peptides through an in Vitro Model of Intestinal Epithelium

Food Digestion

Volumn 3, Issue 1-3, 2012, Pages 16-24

  Del Mar Contreras, María ^a,c   Sancho, Ana I ^b,d   Recio, Isidra ^a   Mills, Clare ^b,e  

^a INSTITUTE OF FOOD SCIENCE RESEARCH CIAL   (Spain)

^b INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^c UNIVERSITY OF GRANADA   (Spain)

^d UNIVERSITY OF SALZBURG   (Austria)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Antihypertensive peptides; Bioavailability; Caco 2 cells; HPLC MS; HT29 MTX cells; Intestinal absorption

Indexed keywords

EID: 84871745882     PISSN: 18691978     EISSN: 18691986     Source Type: Journal    
DOI: 10.1007/s13228-012-0020-2     Document Type: Article

References (40)

1. Avdeef A (2010) Leakiness and size exclusion of paracellular channels in cultured epithelial cell monolayers - interlaboratory comparison. Pharm Res 27:480-489
2. Behrens I, Stenberg P, Artursson P, Kissel T (2001) Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells. Pharm Res 18:1138-1145
3. Chua H-L, Seetharama J, Sim M-K, Go M-L (2004) Transport of angiotensin peptides across the Caco-2 monolayer. Peptides 25:1327-1338
4. Contreras MM (2010) Development of functional ingredients with antihypertensive peptides from milk proteins. PhD Dissertation, University Autonomous of Madrid
5. Contreras MM, Carrón R, Montero MJ, Ramos M, Recio I (2009) Novel casein-derived peptides with antihypertensive activity. Int Dairy J 19:566-573
6. Contreras MM, Gómez-Sala B, Martín-Álvarez PJ, Amigo L, Ramos M, Recio I (2010) Monitoring the large-scale production of the antihypertensive peptides RYLGY and AYFYPEL by HPLC-MS. Anal Bioanal Chem 397:2825-2832
7. Contreras MM, Sevilla MA, Monroy-Ruiz J, Amigo L, Gómez-Sala B, Molina E, Ramos M, Recio I (2011) Food-grade production of an antihypertensive casein hydrolysate and resistance of active peptides to drying and storage. Int Dairy J 21:470-476
8. Deferme S, Annaert P, Augustijns P (2008) In vitro screening models to assess intestinal drug absorption and metabolism. In: Erhardt C, Kim K-J (eds) Drug absorption studies - in situ, in vitro, and in silico models. Springer, New York, pp 182-215
9. Fleisher D (2000) Biological transport phenomena in the gastrointestinal tract: cellular mechanisms. In: Amidon GL, Lee PI, Topp EM (eds) Transport processes in pharmaceutical systems. Marcel Dekker Inc, New York, pp 147-184
10. Foltz M, Cerstiaens A, van Meensel A, Mols R, van der Pijl PC, Duchateau GSMJE, Augustijns P (2008) The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models. Peptides 29:1312-1320
11. Foltz M, Meynen EE, Bianco V, van Platerink C, Koning TMMG, Kloek J (2007) Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. J Nutr 137:953-958
12. Granero GE, Longhi MR, Becker C, Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Dressman JB, Barends DM (2008) Biowaiver monographs for immediate release solid oral dosage forms: acetazolamide. J Pharm Sci 97:3691-3699
13. Hennebicq Reig S, Kim I, Janin A, Grard G, Hémon B, Moreau O, Porchet N, Aubert JP, Degand P, Huet G (1996) Regulation of cathepsin D dependent on the phenotype of colon carcinoma cells. Int J Cancer 68:479-484
14. Hernández-Ledesma B, Contreras MM, Recio I (2011) Antihypertensive peptides: production, bioavailability and incorporation into foods. Adv Colloid Interf Sci 165:23-35
15. Hilgendorf C, Spahn-Langguth H, Regardh CG, Lipka E, Amidon GL, Langguth P (2000) Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeability via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci 89:63-75
16. Howell S, Kenny AJ, Turner AJ (1992) A survey of membrane peptidases in two human colonic cell lines, Caco-2 and HT-29. Biochem J 284:595-601
17. Iwan M, Jarmołowska B, Bielikowicz K, Kostyra E, Kostyra H, Kaczmarski M (2008) Transport of μ-opioid receptor agonists and antagonist peptides across Caco-2 monolayer. Peptides 29:1042-1047
18. Lai SK, Wang Y-Y, Hanes J (2009) Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 61:158-171
19. Lei L, Sun H, Liu D, Liu L, Shimin L (2008) Transport of val-leu-pro-val-pro in human intestinal epithelial (Caco-2) cell monolayers. J Agric Food Chem 56:3582-3586
20. Lesuffleur T, Barbat A, Dussaulx E, Zweibaum A (1990) Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res 50:6334-6343
21. Mahler GJ, Shuler ML, Glahn RP (2009) Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability. J Nutr Biochem 20:494-502
22. Masuda O, Nakamura Y, Takano T (1996) Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides in spontaneously hypertensive rats. J Nutr 126:3063-3068
23. Miguel M, Davalos A, Manso MA, de la Pena G, Lasuncion MA, López-Fandiño R (2008) Transepithelial transport across Caco-2 cell monolayers of antihypertensive egg-derived peptides. PepT1-mediated flux of Tyr-Pro-lle. Mol Nutr Food Res 52:1507-1513
24. Moreno FJ, Rubio LA, Olano A, Clemente A (2006) Uptake of 2S albumin allergens, Ber e 1 and Ses i 1, across human intestinal epithelial Caco-2 cell monolayers. J Agric Food Chem 54:8631-8639
25. Nollevaux G, Devillé C, El Moualij B, Zorzi W, Deloyer P, Schneider Y-J, Peulen O, Dandrifosse G (2006) Development of a serum-free co-culture of human intestinal epithelium cell-lines (Caco-2/HT29-5M21). BMC Cell Biol 7:20
26. Ohsawa K, Satsu H, Ohki K, Enjoh M, Takano T, Shimizu M (2008) Producibility and digestibility of antihypertensive β-casein tripeptides, Val-Pro-Pro and Ile-Pro-Pro, in the gastrointestinal tract: analyses using an in vitro model of mammalian gastrointestinal digestion. J Agric Food Chem 56:854-858
27. Pauletti GM, Gangwar S, Knipp GT, Nerurkar MM, Okumu FW, Tamura K, Siahaan TJ, Borchardt RT (1996) Structural requirements for intestinal absorption of peptide drugs. J Control Release 41:3-17
28. Pontier C, Pachot J, Botham R, Lenfant B, Arnaud P (2001) HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer. J Pharm Sci 90:1608-1619
29. Poquet L, Clifford MN, Williamson G (2008) Transport and metabolism of ferulic acid through the colonic epithelium. Drug Metab Dispos 36:190-197
30. Quirós A, Davalos A, Lasunción MA, Ramos M, Recio I (2008) Bioavailability of the antihypertensive peptide LHLPLP: transepithelial flux of HLPLP. Int Dairy J 18:279-286
31. Sánchez D, Kassan M, Contreras MM, Carrón R, Recio I, Montero M-J, Sevilla M-A (2011) Long-term intake of a milk casein hydrolysate attenuates the development of hypertension and involves cardiovascular benefits. Pharm Res 63:398-404
32. Satake M, Enjoh M, Nakamura Y, Takano T, Kawamura Y, Arai S, Shimizu M (2002) Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Biosci Biotechnol Biochem 66:378-384
33. Shimizu M, Tsunogai M, Arai S (1997) Transepithelial transport of oligopeptides in the human intestinal cell, Caco-2. Peptides 18:681-687
34. Sienkiewicz-Szlapka E, Jarmolowska B, Krawczuk S, Kostyra E, Kostyra H, Bielikowicz K (2009) Transport of bovine milk-derived opioid peptides across a Caco-2 monolayer. Int Dairy J 19:252-257
35. Sun H, Liu D, Li S, Qin Z (2009) Transepithelial transport characteristics of the antihypertensive peptide, Lys-Val-Leu-Pro-Val-Pro, in human intestinal Caco-2 cell monolayers. Biosci Biotechnol Biochem 73:293-298
36. Van der Pijl PC, Kies AK, Ten Have GAM, Duchateau GSMJE, Deutz NEP (2008) Pharmacokinetics of proline-rich tripeptides in the pig. Peptides 29:2196-2202
37. Van Platerink CJ, Janssen H-GM, Horsten R, Haverkamp J (2006) Quantification of ACE inhibiting peptides in human plasma using high performance liquid chromatography-mass spectrometry. J Chromatogr B 830:151-157
38. Vermeirssen V, van Camp J, Verstraete W (2004) Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br J Nutr 92:357-366
39. Walter E, Janich S, Roessler BJ, Hilfinger JM, Amidon GL (1996) HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. J Pharm Sci 85:1070-1076
40. Zhu X-L, Watanabe K, Shiraishi K, Ueki T, Noda Y, Matsui T, Matsumoto K (2008) Identification of ACE-inhibitory peptides in salt-free soy sauce that are transportable across caco-2 cell monolayers. Peptides 29:338-344